These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8857080)

  • 1. A pharmacokinetic-pharmacodynamic model for a muscle relaxant: atracurium.
    Nigrovic V; Gaspari J; Banoub M
    Eur J Clin Pharmacol; 1996; 49(4):325-32. PubMed ID: 8857080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic modelling of a parent drug and its metabolite. Atracurium and laudanosine.
    Nigrovic V; Banoub M
    Clin Pharmacokinet; 1992 May; 22(5):396-408. PubMed ID: 1505145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic method for the determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics.
    Farenc C; Audran M; Lefrant JY; Mazerm I; Bressolle F
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):117-26. PubMed ID: 10202964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid concentrations of atracurium, laudanosine and vecuronium following clinical subarachnoid hemorrhage.
    Tassonyi E; Fathi M; Hughes GJ; Chiodini F; Bertrand D; Muller D; Fuchs-Buder T
    Acta Anaesthesiol Scand; 2002 Nov; 46(10):1236-41. PubMed ID: 12421196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
    Boyd AH; Eastwood NB; Parker CJ; Hunter JM
    Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients.
    Farenc C; Lefrant JY; Audran M; Bressolle F
    J Clin Pharmacol; 2001 Jan; 41(1):44-50. PubMed ID: 11144993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 51W89: preliminary data.
    Hunter JM; Eastwood NB; Boyd AH; Parker CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():94. PubMed ID: 8533555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients.
    Smith CE; van Miert MM; Parker CJ; Hunter JM
    Anaesthesia; 1997 Sep; 52(9):833-41. PubMed ID: 9349062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age on cis-atracurium besylate pharmacokinetics following a single 1 mg kg
    Aguilar A; Andaluz A; Moll X; Cristòfol C; García F
    Vet Anaesth Analg; 2019 Sep; 46(5):643-651. PubMed ID: 31155378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].
    Savarese JJ; Lien CA; Belmont MR; Wastila WB
    Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and atracurium and laudanosine concentrations during a fixed continuous infusion of atracurium in mechanically ventilated patients with acute respiratory distress syndrome.
    Lefrant JY; Farenc C; De la Coussaye JE; Muller L; Ripart J; Cuvillon P; Saissi G; Eledjam JJ
    Anaesth Intensive Care; 2002 Aug; 30(4):422-7. PubMed ID: 12180578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure.
    Fahey MR; Rupp SM; Fisher DM; Miller RD; Sharma M; Canfell C; Castagnoli K; Hennis PJ
    Anesthesiology; 1984 Dec; 61(6):699-702. PubMed ID: 6239574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion.
    Grigore AM; Brusco L; Kuroda M; Koorn R
    Crit Care Med; 1998 Jan; 26(1):180-3. PubMed ID: 9428564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation.
    De Wolf AM; Freeman JA; Scott VL; Tullock W; Smith DA; Kisor DF; Kerls S; Cook DR
    Br J Anaesth; 1996 May; 76(5):624-8. PubMed ID: 8688259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma during intracranial surgery.
    Eddleston JM; Harper NJ; Pollard BJ; Edwards D; Gwinnutt CL
    Br J Anaesth; 1989 Nov; 63(5):525-30. PubMed ID: 2605068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium.
    Varin F; Ducharme J; Théorêt Y; Besner JG; Bevan DR; Donati F
    Clin Pharmacol Ther; 1990 Jul; 48(1):18-25. PubMed ID: 2369806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New muscle relaxants].
    Diefenbach C; Buzello W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):2-8. PubMed ID: 8868525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma laudanosine levels in patients given atracurium during liver transplantation.
    Lawhead RG; Matsumi M; Peters KR; Landers DF; Becker GL; Earl RA
    Anesth Analg; 1993 Mar; 76(3):569-73. PubMed ID: 8452269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and dynamics of atracurium infusions after paediatric orthotopic liver transplantation.
    Chow B; Bowden MI; Ho E; Weatherley BC; Bion JF
    Br J Anaesth; 2000 Dec; 85(6):850-5. PubMed ID: 11732518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure.
    Eastwood NB; Boyd AH; Parker CJ; Hunter JM
    Br J Anaesth; 1995 Oct; 75(4):431-5. PubMed ID: 7488483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.